Total Payments
$833.17
2021 Payments
$70.24
Companies
11
Transactions
39
Medicare Patients
1,199
Medicare Billing
$62,003
Payment Breakdown by Category
Food & Beverage$733.22 (88.0%)
Education$99.95 (12.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $733.22 | 38 | 88.0% |
| Education | $99.95 | 1 | 12.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $373.19 | 15 | $0 (2020) |
| Hologic, LLC | $115.05 | 5 | $0 (2018) |
| AbbVie Inc. | $105.86 | 3 | $0 (2021) |
| PFIZER INC. | $90.60 | 7 | $0 (2019) |
| CooperSurgical, Inc. | $34.97 | 2 | $0 (2019) |
| Cogentix Medical Inc. | $33.25 | 2 | $0 (2017) |
| Duchesnay USA Incorporated | $23.57 | 1 | $0 (2017) |
| Allergan Inc. | $19.33 | 1 | $0 (2017) |
| TherapeuticsMD, Inc. | $13.86 | 1 | $0 (2019) |
| DENTSPLY IH Inc. | $12.65 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $70.24 | 1 | AbbVie Inc. ($70.24) |
| 2020 | $20.13 | 1 | Astellas Pharma US Inc ($20.13) |
| 2019 | $311.47 | 17 | Astellas Pharma US Inc ($201.35) |
| 2018 | $246.51 | 10 | Astellas Pharma US Inc ($151.71) |
| 2017 | $184.82 | 10 | HOLOGIC INC ($84.18) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/25/2021 | AbbVie Inc. | ORIAHNN (Drug) | Food and Beverage | In-kind items and services | $70.24 | General |
| Category: WOMENS HEALTH | ||||||
| 02/26/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: UROLOGY | ||||||
| 12/11/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: UROLOGY | ||||||
| 12/11/2019 | DENTSPLY IH Inc. | LoFric (Device) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Medical Urology | ||||||
| 12/03/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: UROLOGY | ||||||
| 11/21/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Endocrinology | ||||||
| 11/20/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: UROLOGY | ||||||
| 10/30/2019 | TherapeuticsMD, Inc. | IMVEXXY (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | ||||||
| 10/21/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: UROLOGY | ||||||
| 10/02/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: UROLOGY | ||||||
| 09/20/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: UROLOGY | ||||||
| 08/21/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: UROLOGY | ||||||
| 06/27/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: UROLOGY | ||||||
| 04/29/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Endocrinology | ||||||
| 04/23/2019 | Astellas Pharma US Inc | VESICARE (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $7.20 | General |
| Category: UROLOGY | ||||||
| 04/04/2019 | CooperSurgical, Inc. | Endosee (Device) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
| 03/26/2019 | PFIZER INC. | PREMARIN (Drug), ESTRING, COLOGUARD | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: WOMENS HEALTH | ||||||
| 03/20/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: UROLOGY | ||||||
| 01/09/2019 | PFIZER INC. | PREMARIN (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: WOMENS HEALTH | ||||||
| 12/18/2018 | CooperSurgical, Inc. | Endosee (Device) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
| 11/07/2018 | Astellas Pharma US Inc | VESICARE (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: UROLOGY | ||||||
| 10/30/2018 | PFIZER INC. | PREMARIN (Drug), ESTRING | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: WOMENS HEALTH | ||||||
| 09/04/2018 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.95 | General |
| 08/28/2018 | PFIZER INC. | PREMARIN (Drug), ESTRING | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: WOMENS HEALTH | ||||||
| 07/25/2018 | PFIZER INC. | PREMARIN (Drug), ESTRING | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 366 | 425 | $55,779 | $18,903 |
| 2022 | 4 | 348 | 418 | $53,316 | $18,050 |
| 2021 | 4 | 290 | 360 | $40,915 | $14,088 |
| 2020 | 4 | 195 | 239 | $33,417 | $10,962 |
Total Patients
1,199
Total Services
1,442
Medicare Billing
$62,003
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 114 | 115 | $18,302 | $7,352 | 40.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 136 | $14,035 | $5,981 | 42.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 145 | 145 | $19,055 | $3,839 | 20.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $4,387 | $1,731 | 39.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 99 | 99 | $15,466 | $6,566 | 42.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 134 | $13,651 | $5,962 | 43.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 160 | 160 | $20,402 | $4,314 | 21.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $3,796 | $1,208 | 31.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 93 | 163 | $15,636 | $7,422 | 47.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 154 | 154 | $19,082 | $4,198 | 22.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 27 | $3,969 | $1,652 | 41.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 16 | 16 | $2,227 | $816.29 | 36.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 65 | 109 | $16,026 | $5,255 | 32.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 81 | 81 | $9,728 | $3,183 | 32.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 21 | 21 | $4,559 | $1,335 | 29.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 28 | 28 | $3,105 | $1,190 | 38.3% |
About Dr. Helene Longacre, MD
Dr. Helene Longacre, MD is a Gynecology healthcare provider based in Vestal, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972544237.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Helene Longacre, MD has received a total of $833.17 in payments from pharmaceutical and medical device companies, with $70.24 received in 2021. These payments were reported across 39 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($733.22).
As a Medicare-enrolled provider, Longacre has provided services to 1,199 Medicare beneficiaries, totaling 1,442 services with total Medicare billing of $62,003. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecology
- Location Vestal, NY
- Active Since 06/09/2006
- Last Updated 05/23/2023
- Taxonomy Code 207VG0400X
- Entity Type Individual
- NPI Number 1972544237
Products in Payments
- MYRBETRIQ (Drug) $228.20
- NovaSure and MyoSure (Device) $74.07
- ORIAHNN (Drug) $70.24
- PREMARIN (Drug) $65.98
- VESICARE (Drug) $45.04
- Orilissa (Drug) $35.62
- Endosee (Device) $34.97
- Urgent PC (Device) $33.25
- NovaSure (Device) $30.87
- PREMARIN ORALS (Drug) $24.62
- Osphena (Drug) $23.57
- BOTOX OAB (Drug) $19.33
- IMVEXXY (Drug) $13.86
- LoFric (Device) $12.65
- BMD-Magic3 Catheter (Device) $10.84
- MyoSure NovaSure (Device) $10.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.